Indication

Chronic thromboembolic pulmonary hypertension

Chronic thromboembolic pulmonary hypertension is a rare, progressive form of precapillary pulmonary hypertension (classified as World Health Organization Group 4) that affects the pulmonary vascular bed and right heart. Read more about Chronic thromboembolic pulmonary hypertension

2 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Chronic thromboembolic pulmonary hypertension therapies.

Showing 1–2 of 2 drugs

ADEMPAS (riociguat)

PULMONARY ANTIHYPERTENSIVE AGENTS, CGMP PATHWAY·PULMONARY ARTERIAL HYPERTENSION·+1
Bayer HealthCare

RIOCIGUAT

PULMONARY ANTIHYPERTENSIVE AGENTS, CGMP PATHWAY·PULMONARY ARTERIAL HYPERTENSION·+1
ZYDUS PHARMACEU
Filter & compare in the drug finder →Opens the drug finder with Chronic thromboembolic pulmonary hypertension preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chronic thromboembolic pulmonary hypertension.

Chronic thromboembolic pulmonary hypertension is a rare, progressive form of precapillary pulmonary hypertension (classified as World Health Organization Group 4) that affects the pulmonary vascular bed and right heart.

It arises when single or recurrent pulmonary thromboemboli fail to resolve, transforming into organized, fibrotic material that obstructs the large elastic pulmonary arteries.

This mechanical obstruction, coupled with secondary microvascular remodeling in non-occluded vessels, progressively elevates pulmonary vascular resistance and pulmonary arterial pressure.

Clinically, affected patients present with worsening exertional dyspnea, exercise intolerance, and fatigue, which can advance to overt right ventricular failure and premature death if untreated.

Personalize your experience

Follow Chronic thromboembolic pulmonary hypertension and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it